Zhejiang Cancer Hospital: all 281 studies

Page 2 of 3. Open to participants first (116), then studies with results posted, then the rest; newest registration first within each.

• Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination DeficiencyNot yet recruitingNCT05461690Phase 2
• Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell CancerNot yet recruitingNCT05322499Phase 2
• ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCLRecruitingNCT05290090Phase 2
• Retrospective Study of BrachytherapyRecruitingNCT05242861
• A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal CancerNot yet recruitingNCT05183958Phase 2
• UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal CancerRecruitingNCT05148767Phase 4
• Immune Score Based Radiomics in Nasopharyngeal CarcinomaRecruitingNCT05126160
• The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast CancerRecruitingNCT05075512Phase 2
• Para-aortic Prophylactic Irradiation for Locally Advanced Cervical CancerRecruitingNCT04974346Phase 3
• RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast CancerNot yet recruitingNCT04972448
• HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal MetastasisNot yet recruitingNCT04889768Not applicable
• Neoadjuvant Short-course Radiotherapy Followed by the Combination of Immunotherapy and Chemotherapy in Locally Advanced Rectal CancerNot yet recruitingNCT04663763Phase 2
• A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLCRecruitingNCT04543890Phase 2
• Adujvant CT+CRT vs Adujvant CT After D2 Resection for Locally Advanced Proximal Gastric AdenocarcinomaRecruitingNCT03973008Phase 3
• PET/MR in Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT03657017Not applicable
• Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic LesionsRecruitingNCT03129412Phase 2
• CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast CancerCompletedNCT02992067Results posted
• Retlirafusp Alfa Plus SOX and Intraperitoneal Nab-Paclitaxel for Advanced Gastric/GEJ Cancer With Malignant AscitesActive, not recruitingNCT07855757Not applicable
• Development of a Pan-Cancer Screening Model Based on Blood BiomarkersActive, not recruitingNCT07554157
• IT-TT as an Effective and Well-Tolerated Strategy for CNS Prop in High-Risk DLBCL: a Prospective Ph II StudyCompletedNCT07493486Phase 2
• Construction of a Predictive Model for the Efficacy of Chemoprevention Combined With Targeted Therapy in Pancreatic CancerActive, not recruitingNCT07326150
• Establishment of a Predictive Model for Immunotherapy Response in Pancreatic CancerActive, not recruitingNCT07271823
• Effect of Small Double-lumen Tube on the Intubation Time of Thoracoscopic Pulmonectomy in Asian WomenCompletedNCT07097584Not applicable
• Effect of Trendelenburg Positioning on Anesthesia-Induced Hypotension in Elderly PatientsCompletedNCT06968091Not applicable
• Real World Study of Bone Metastases in Patients with Advanced Breast CancerCompletedNCT06873997
• The Formulation of Compound Phellinus Igniarius Decoction on Radiation PneumonitisCompletedNCT06861179Phase 1
• Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal SurgeryCompletedNCT06704698Not applicable
• Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian CancerCompletedNCT06624878Not applicable
• Effect of Esketamine on Anxiety State in Patients Undergoing Abdominal Tumor SurgeryCompletedNCT06530706Not applicable
• A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for SCLCCompletedNCT06478043Phase 2
• Disitamab Vedotin Plus Cadonilimab in Patients With HER2 Mutant Advanced or Metastatic Bile Duct AdenocarcinomaStatus unknownNCT06383533Phase 2
• GMA-Tulip, I-gel and the LMA-Supreme (LMA-S) Devices in Airway Management (GLAM-I)CompletedNCT06383494Not applicable
• Ciprofol EC50 for Inducing Loss of Consciousness in Elderly PatientsCompletedNCT06253078Phase 4
• SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract CarcinomaSuspendedNCT06199882Phase 2
• Serplulimab for Patients With Non-small Cell Lung Cancer (NSCLC) With TPS ≥ 50%: a Prospective, Single-center, Single-arm Phase 2 Study.Active, not recruitingNCT06195683Phase 2
• Postoperative Analgesia With Liposomal Bupivacaine Versus Standard Bupivacaine Combined With DexamethasoneCompletedNCT06173466Phase 4
• A Multi-omics-based Metabolic Typing Study of Gastric CancerActive, not recruitingNCT06134011
• Dalpiciclib Combination With Fulvestrant and Compound Gossyfol Acetate Tablets in Women With CDK4/6 Inhibitor-refractory HR-positive HER-2 Negtive Metastatic Breast Cancer: a Phase 2 Clinical Trial.Status unknownNCT06133088Phase 2
• The Effects of Hemodilution Methods in Patients Undergoing Primary Debulking Gynaecological SurgeryCompletedNCT06103214Not applicable
• Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT06055816Phase 2
• Preliminary Experimental Study on Key Technologies for Early Screening of Gastric CancerStatus unknownNCT05991947
• Mechanism of Gastric Signet Ring Cell Carcinoma Based on MicroproteomicsActive, not recruitingNCT05985577
• Cetuximab in Combination With Dabrafenib and Tislelizumab in BRAF Mutated Treatment of Advanced Colorectal CancerStatus unknownNCT05963087Not applicable
• Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT05813626Phase 2
• Multi-omics Study of Tongue Coating in Malignant Tumors of Digestive TractStatus unknownNCT05794841
• DLCS for Predicting Neoadjuvant Chemotherapy ResponseStatus unknownNCT05617469
• Whether Opioids Are Factor That Induced POD?CompletedNCT05596071Not applicable
• Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder CancerStatus unknownNCT05564897Phase 2
• Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBCStatus unknownNCT05550090
• Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction AdenocarcinomaStatus unknownNCT05528367Phase 2
• Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating TumorCompletedNCT05502458Phase 2
• A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor ExposureActive, not recruitingNCT05489926Phase 2
• Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under BronchoscopyCompletedNCT05468671Phase 4
• Transversus Thoracic Muscle Plane Combined With Pectoral Nerves Block for Breast Cancer SurgeryCompletedNCT05448638Not applicable
• The Role of Clean Intermittent Catheterization in Patients Undergoing Radiotherapy After Radical Hysterectomy for Cervical CancerCompletedNCT05410444Not applicable
• SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint InhibitorsStatus unknownNCT05387044Phase 2
• A Retrospective Study of Immunotherapy in Conversion Therapy of Unresectable Gastric CancerStatus unknownNCT05385809
• The 90% Effective Flow of High Flow Nasal Oxygenation (HFNO) During Sedated BronchoscopyCompletedNCT05298319Not applicable
• Early Detection of Gastric Cancer Using Plasma Cell-free DNA FragmentomicsStatus unknownNCT05269056
• A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical CancerStatus unknownNCT05247619Phase 2
• H101 Combined With Camrelizumab for Recurrent Cervical CancerStatus unknownNCT05234905Phase 2
• Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal CarcinomaStatus unknownNCT05232552Phase 2
• A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLCActive, not recruitingNCT05228496Phase 2
• HFNC and Hypoxia/Desaturation During Radiofrequency Ablation Under Moderate Sedation: A Randomized Clinical TrialCompletedNCT05212064Not applicable
• Radiotherapy Combined With Tislelizumab and Irinotecan in MSS/pMMR Recurrence and Metastatic Colorectal CancerStatus unknownNCT05160727Phase 2
• Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBCStatus unknownNCT05131841Phase 4
• PTC Guiding Neoadjuvant Treatment in Breast CancerCompletedNCT05103293Phase 2
• Dendrobium Huoshanense Suppository in Rectal CancerStatus unknownNCT05079438Phase 3
• Efficacy of Everolimus-containing Chemotherapy in HER2- mBC Patients With PI3K/AKT/mTOR Mutations StudyCompletedNCT05054166
• Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular CarcinomaStatus unknownNCT05053386Not applicable
• A Study of Diarrhea and Intestinal Flora Changes Caused by Pyrotinib in Breast CancerStatus unknownNCT05030519
• Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCCStatus unknownNCT05007587Early Phase 1
• A Phase II Study of Sintilimab Combined With Anlotinib in Treatment of ED-SCLCStatus unknownNCT04967625Phase 2
• A Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area LymphomaStatus unknownNCT04860674Phase 2
• Tumor Response Time of Palbociclib in Combination With AI in Real-world Chinese PatientsStatus unknownNCT04858997Phase 2
• Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain MetastasesActive, not recruitingNCT04808752Phase 2
• Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors DiagnosisCompletedNCT04793672
• Sintilimab Combined With Anlotinib in Advanced NSCLC With EGFR Uncommon MutationsCompletedNCT04790409Phase 2
• A Trial of Sintilimab Plus Anlotinib For Metastatic NSCLC After First-Line PD-1 InhibitorCompletedNCT04691388Phase 2
• Anlotinib to Malignant Brainstem GliomaStatus unknownNCT04668508Phase 2
• Anterior Quadratus Lumborum Block at the Lateral Supra-arcuate Ligament for Analgesia After Open Liver SurgeryCompletedNCT04668391Not applicable
• Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast CancerStatus unknownNCT04665986Phase 3
• Preliminary Efficacy Analysis of Cheng's Giraffe Reconstruction After Proximal GastrectomyStatus unknownNCT04657848Not applicable
• TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma (Prolong)Status unknownNCT04560751
• A Clinical Study Of Camrelizumab With Or Without Radiotherapy In The Treatment Of Esophageal CancerStatus unknownNCT04512417Phase 2
• Camrelizumab in Combination With Neoadjuvant Chemotherapy for Resectable Thoracic Esophageal Squamous Cell CarcinomaActive, not recruitingNCT04506138Phase 1/2
• A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)Status unknownNCT04446091Phase 1/2
• The Combination of Camrelizumab and Apatinib as Second-line Therapy for Advanced Pancreatic CarcinomaStatus unknownNCT04415385Phase 2
• Rituximab Combined With Chidamide and Lenalidomide for r/r AITLStatus unknownNCT04319601Not applicable
• Anlotinib in Combination With PD1 With Gemcitabine Plus(+)Cisplatin for Unresectable or Metastatic Biliary Tract CancerStatus unknownNCT04300959Phase 2
• Camrelizumab Combined With Local Treatment in NSCLC Patients With BMStatus unknownNCT04291092Phase 2
• Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung CancerCompletedNCT04266691
• Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint TestStatus unknownNCT04264468
• Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC)Status unknownNCT04255836Phase 2
• Preoperative Systemic Therapy vs Upfront Surgery in HER2 Positive Early Breast CancerCompletedNCT04249440
• Clinical Study on the First-line Treatment of Advanced Biliary System Tumors With Tripley Monoclonal Antibody Combined With GEMOX RegimenStatus unknownNCT04191343Phase 2
• Toripalimab Combined With Apatinib Mesylate for the Treatment of Gastric Adenocarcinoma in a Prospective Randomized Multicenter Phase II Clinical StudyStatus unknownNCT04190745Phase 2
• Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLCStatus unknownNCT04189094Phase 2
• Single Cell Sequencing Analysis of ThymomaStatus unknownNCT04162691
• Endostar Combined With Concurrent Radiochemotherapy for Treatment of Unresectable Stage III NSCLCStatus unknownNCT04161352

← Zhejiang Cancer Hospital overview and focus areas